The company
Erasca, Inc.
ERAS · Nasdaq
ERAS stood above a rising 150-day average in 47 of the last 52 weekly readings, and has been out of that trend for the last 5 weeks. It is 7.2% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−14 points in four weeks); Health Care: 28% (−9 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 5
- Industry in uptrend
- 18% -14 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $4.6M
- Officials’ trades on record
- 1
- Institutions holding
- 248 (+32)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 47 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
1 disclosed lines: House 0, Senate 0, executive 1; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Scott A. Kupor Executive branch: Office of Government EthicsOffice of Personnel Management | sold | $1k–$15k | 30 Jul 2026filed 30 Sep 2026 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Ebun GarnerChief Legal Officer | sold | 80,000at $16.40 | 1 Apr 2026filed 3 Apr 2026 |
| Shannon MorrisChief Medical Officer | sold | 20,000at $15.04 | 4 Mar 2026filed 6 Mar 2026 |
| Ebun GarnerGeneral Counsel & Corp. Sec. | sold | 120,000at $5.59 | 7 Jan 2026filed 8 Jan 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Frazier Life Sciences Management, L.P.added · filed 14 Aug 2026 | 24,975,188$457.5M | +300,000+1.2% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 21,154,146$387.5M | +1,002,740+5.0% |
| RTW INVESTMENTS, LPadded · filed 14 Aug 2026 | 17,946,754$328.8M | +1,789,579+11.1% |
| Venrock Adviser, LLCadded · filed 14 Aug 2026 | 17,891,812$327.8M | +1,509,000+9.2% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 12,184,555$223.2M | +2,884,471+31.0% |
| Logos Global Management LPadded · filed 14 Aug 2026 | 12,150,000$222.6M | +1,000,000+9.0% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 11,402,199$208.9M | +152,461+1.4% |
| Siren, L.L.C.added · filed 13 Aug 2026 | 11,397,781$208.8M | +153,535+1.4% |
| Paradigm Biocapital Advisors LPreduced · filed 14 Aug 2026 | 9,550,000$175.0M | -842,702−8.1% |
| ARCH Venture Management, LLCunchanged · filed 14 Aug 2026 | 7,091,557$129.9M | 00.0% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.